Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Genoa Ventures, LLC

Genoa Ventures, LLC

Institutional venture firmSan Francisco, CAgenoavc.comSEC venture capital fund adviser

Investing in Early-Stage Companies Innovating at the Intersection of Biology and Technology.

venture manager, reported GAV $137M across 8 vehicles

Importance
33
moderate
Active deployment
30
moderate
Emerging
0
low
Completeness
63
high
Freshness
100
high
Research priority
14
low
Identity and regulatory footprint
Headquarters
San Francisco, CAadviserinfo.sec.gov
Office address
100 PINE ST. SUITE 2250, San Francisco, CA, 94111adviserinfo.sec.gov
Business phone
415-580-0050adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 31, 2026
Private funds reported
8 (8 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$103Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business email
jenny@genoavc.comgenoavc.compublished by the subject
business phone
415-580-0050adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
15 observed deals
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 80%Biotechnology 13%Other Technology 7%
lead rate n/afollow-on rate n/anew logos, 12 months 15
Funds and vehicles
8 reported, 1 no longer reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Genoa Opportunity Spv IV, LLCSPV or co-invest vehicle2022 adv first reportedActive deployment$11.0M
Mar 29, 2024
8$0
of $11.0M
Aug 19, 2021
Genoa Ventures Fund Ii-A, LPFeeder or parallel2022 adv first reportedActive deployment$1.2M
Mar 29, 2024
11$0Nov 29, 2021
Genoa Ventures Fund II, L.P.Fund2021 form d first saleMature$77.9M
Mar 29, 2024
129$56.7MJan 14, 2022
Genoa Opportunity Spv V, LLCSPV or co-invest vehicle2021 form d first saleMature$1.1M
Mar 29, 2024
11$1.1M
of $1.1M
Oct 13, 2021
Genoa Opportunity Spv II, LLCSPV or co-invest vehicle2020 form d first saleMature$7.6M
Mar 29, 2024
4$1.3M
of $1.3M
Sep 23, 2020
Genoa Opportunity Spv III, LLCSPV or co-invest vehicle2020 form d first saleMature$200,109
Mar 29, 2024
3$197,500
of $197,500
Mar 11, 2021
Genoa Ventures Fund I, LPFund2018 form d first saleHarvest$38.4M
Mar 29, 2024
93$24.1MMay 14, 2019
Genoa Ventures Fund III, LPFundunknownUnknownunknownunknown$0Jun 27, 2024
Genoa Opportunity Spv I, LLCSPV or co-invest vehicle2020 adv first reportedWound down$58,542
Mar 29, 2023
8unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
2 current, 0 departed
Investments on record
15 edges, 15 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
Adventurereadybrandsportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Attuneportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Bond Pet Foodsportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
BrainBoxportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
BrightSpec, Inc.portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Codetta Bio Inc.portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Cultureportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Epitelportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Fellowportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Hermesbioportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Intervennportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Redux Bioportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
SimBioSys, Inc.portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
Tropicportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
ZwitterCoportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
14 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
  1. Mar 29, 2024
    Genoa Opportunity Spv I, LLC no longer reported on Form ADV by Genoa Ventures, LLC
  2. Mar 31, 2022
    Genoa Opportunity Spv V, LLC first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $1,091,400
  3. Mar 31, 2022
    Genoa Ventures Fund Ii-A, LP first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $1,250,000
  4. Mar 31, 2022
    Genoa Opportunity Spv IV, LLC first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $10,970,000
  5. Mar 31, 2021
    Genoa Opportunity Spv II, LLC first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $1,265,000
  6. Mar 31, 2021
    Genoa Opportunity Spv III, LLC first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $197,500
  7. Mar 31, 2021
    Genoa Ventures Fund II, L.P. first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $33,375,000
  8. Mar 25, 2020
    Genoa Opportunity Spv I, LLC first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $2,370,247
  9. Mar 19, 2019
    Genoa Ventures, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
  10. Mar 19, 2019
    Genoa Ventures Fund I, LP first reported on Form ADV by Genoa Ventures, LLC (Venture Capital Fund), GAV $20,551,020
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $137M across 8 vehicles
Evidence
43 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2019-03-19Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-31Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-29Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2019-03-19Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone415-580-0050Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone415-580-0050Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://www.genoavc.com/contact
contact page linked from the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionInvesting in Early-Stage Companies Innovating at the Intersection of Biology and Technology.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionInvesting in Early-Stage Companies Innovating at the Intersection of Biology and Technology.
meta description
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersSan Francisco, CAMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersSan Francisco, CAMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address100 PINE ST. SUITE 2250, San Francisco, CA, 94111Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address100 PINE ST. SUITE 2250, San Francisco, CA, 94111Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://www.genoavc.com/portfolio
15 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://www.genoavc.com/portfolio
15 entries read
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported8Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported7Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$103MMar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$137MMar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Team pagehttps://www.genoavc.com/team
1 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://www.genoavc.com/team
1 name/title pairs read
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported8Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported7Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://www.genoavc.com/Mar 31, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Websitehttps://www.genoavc.com/Mar 29, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleGenoa Ventures
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleGenoa Ventures
title tag
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)